Stockscreener 앱 받기
22.00
3.97%
-0.91
시간 외 거래:
22.44
0.44
+2.00%
전일 마감가:
$22.91
열려 있는:
$23.13
하루 거래량:
330.47K
Relative Volume:
0.40
시가총액:
$1.34B
수익:
-
순이익/손실:
$-197.68M
주가수익비율:
-5.8511
EPS:
-3.76
순현금흐름:
$-158.88M
1주 성능:
+4.71%
1개월 성능:
-21.60%
6개월 성능:
+158.22%
1년 성능:
+340.88%
1일 변동 폭
$21.20
$23.27
1주일 범위
$21.20
$24.66
52주 변동 폭
$1.92
$31.18
Kodiak Sciences Inc Stock (KOD) Company Profile
명칭
Kodiak Sciences Inc
전화
650-281-0850
주소
1250 PAGE MILL RD, PALO ALTO, CA
Compare KOD vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
22.00 | 1.40B | 0 | -197.68M | -158.88M | -3.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-11 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-10-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-09-25 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2025-09-22 | 개시 | Jefferies | Buy |
| 2025-08-14 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-12-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-05 | 개시 | H.C. Wainwright | Neutral |
| 2023-12-11 | 재개 | Goldman | Sell |
| 2023-11-17 | 업그레이드 | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-07-25 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-07-24 | 다운그레이드 | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-11-15 | 개시 | CapitalOne | Overweight |
| 2022-08-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-02-24 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2022-02-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-05-11 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2021-03-12 | 개시 | Evercore ISI | Outperform |
| 2021-03-01 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2021-02-17 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2021-01-25 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-12-11 | 개시 | Citigroup | Neutral |
| 2020-11-30 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-11-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-31 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-03 | 개시 | Goldman | Buy |
| 2020-02-18 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-02-06 | 개시 | SunTrust | Buy |
| 2020-01-08 | 개시 | ROTH Capital | Buy |
| 2020-01-03 | 개시 | Jefferies | Buy |
| 2019-12-24 | 개시 | JP Morgan | Overweight |
| 2019-10-15 | 재확인 | Chardan Capital Markets | Buy |
| 2019-02-20 | 개시 | Chardan Capital Markets | Buy |
| 2018-10-29 | 개시 | Barclays | Overweight |
| 2018-10-29 | 개시 | BofA/Merrill | Buy |
| 2018-10-29 | 개시 | Morgan Stanley | Overweight |
모두보기
Kodiak Sciences Inc 주식(KOD)의 최신 뉴스
H.C. Wainwright reiterates Buy rating on Kodiak Sciences stock at $38 - Investing.com Nigeria
H.C. Wainwright reiterates Buy rating on Kodiak Sciences stock at $38 By Investing.com - Investing.com South Africa
KOD: HC Wainwright & Co. Reiterates Buy Rating with $38 Target | - GuruFocus
HC Wainwright Reaffirms Buy Rating for Kodiak Sciences (NASDAQ:KOD) - MarketBeat
KOD Stock Up 24% in 3 Months: Here's What You Need to Know - TradingView
Aug PostEarnings: Can Kodiak Sciences Inc lead its sector in growthEarnings Miss & Precise Entry and Exit Recommendations - baoquankhu1.vn
Kodiak Sciences to present final APEX study results at Angiogenesis meeting - Investing.com Nigeria
Kodiak Sciences to present final APEX study results at Angiogenesis meeting By Investing.com - Investing.com South Africa
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026 - marketscreener.com
Kodiak Sciences (KOD) Price Target Increased by 11.69% to 31.33 - Nasdaq
Kodiak Sciences raises capital through completed stock offering - MSN
Kodiak Sciences: A Stellar Move (NASDAQ:KOD) - Seeking Alpha
Aug Catalysts: Is Kodiak Sciences Inc exposed to currency risks2025 Volatility Report & Capital Protection Trading Alerts - baoquankhu1.vn
Aug Retail: Will Kodiak Sciences Inc outperform the market in YEAR - baoquankhu1.vn
Kodiak Sciences (NASDAQ:KOD) Trading 6.5% HigherHere's Why - MarketBeat
Can Kodiak Sciences (KOD) Funding And Readouts Reshape Its Retinal Disease Treatment Narrative? - Sahm
FY2025 EPS Estimates for Kodiak Sciences Lifted by Analyst - MarketBeat
Head to Head Review: Structure Therapeutics (NASDAQ:GPCR) and Kodiak Sciences (NASDAQ:KOD) - Defense World
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 7.6%Here's Why - MarketBeat
HC Wainwright Predicts Kodiak Sciences FY2030 Earnings - MarketBeat
Kodiak Sciences Reaches Analyst Target Price - Nasdaq
Kodiak Sciences (NASDAQ:KOD) Concentrates on Vision Preservation - Kalkine Media
Kodiak Sciences stock price target raised to $38 from $26 at H.C. Wainwright By Investing.com - Investing.com Nigeria
Kodiak Sciences stock price target raised to $38 from $26 at H.C. Wainwright - Investing.com Nigeria
KOD: Analyst Raises Price Target to $38 with Buy Rating | KOD St - GuruFocus
H.C. Wainwright Maintains Kodiak Sciences(KOD.US) With Buy Rating, Raises Target Price to $38 - 富途资讯
Kodiak Sciences (KOD) Valuation Check As Phase 3 Readouts And Capital Raise Focus Investor Attention - Sahm
Kodiak Sciences Is Riding A 325% Run Into Big Retina Readouts - Finimize
Aug Weekly: Is Kodiak Sciences Inc exposed to currency risksStop Loss & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Why Kodiak Sciences Inc. stock is in analyst buy zoneMarket Performance Report & Technical Analysis for Trade Confirmation - bollywoodhelpline.com
Chart Watch: Can Kodiak Sciences Inc lead its sector in growthJuly 2025 Technicals & Entry Point Confirmation Alerts - baoquankhu1.vn
Kodiak Sciences Inc. (NASDAQ:KOD) Short Interest Update - MarketBeat
First Week of December 18th Options Trading For Kodiak Sciences (KOD) - Nasdaq
Kodiak Sciences (KOD) Price Target Increased by 24.19% to 28.05 - Nasdaq
Is Kodiak Sciences Inc. (K27) stock included in top ETFsStock Screening Results & Exceptional Growth Portfolio - bollywoodhelpline.com
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 7.7%Here's What Happened - MarketBeat
Hedge Fund Bets: Will Kodiak Sciences Inc benefit from seasonalityRate Hike & Safe Entry Momentum Tips - baoquankhu1.vn
Is It Too Late To Consider Kodiak Sciences (KOD) After Its 233% One-Year Surge? - Yahoo Finance
Kodiak Sciences Inc. (NASDAQ:KOD) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Kodiak Sciences (KOD) price target increased by 19.36% to 21.71 - MSN
How analysts rate Kodiak Sciences Inc. stock todayQuarterly Portfolio Report & Risk Controlled Swing Trade Alerts - ulpravda.ru
Kodiak Sciences (NASDAQ:KOD) Rating Increased to Strong-Buy at UBS Group - MarketBeat
Is Kodiak Sciences Inc. (K27) stock inflation resilient2025 Stock Rankings & Momentum Based Trading Signals - Улправда
Will Kodiak Sciences Inc. stock outperform value stocksTake Profit & Accurate Entry/Exit Alerts - ulpravda.ru
Is Kodiak Sciences (KOD) Pricing Reflect Recent Biotech Pipeline And Funding Developments Accurately - Sahm
Is Kodiak Sciences Inc. stock safe for conservative investorsWatch List & AI Powered Trade Plan Recommendations - Улправда
Can Kodiak Sciences Inc. stock weather global recessionJuly 2025 Institutional & Fast Moving Stock Trade Plans - Улправда
Kodiak Sciences Inc (KOD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Kodiak Sciences Inc 주식 (KOD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BORGESON JOHN A. | See Remarks |
Jun 17 '25 |
Sale |
3.65 |
723 |
2,640 |
183,316 |
1.24%
0.19%
자본화:
|
볼륨(24시간):